Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Men's Health Market Research

Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

Best Price Guarantee Length Publisher Published Date SKU
from $3,990 140 Pages Renub Research November, 2022 RNBR17540068
Best Price Guarantee
Price from $3,990
Length 140 Pages
Publisher Renub Research
Published Date November, 2022
SKU RNBR17540068

Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

Global Hormone Replacement Therapy Market is expected to reach US$ 25.09 Billion by 2027 according to Renub Research. Over the years, hormone replacement therapy has been widely used to treat disorders associated with Menopause in women, which has positively influenced the reduction of hot flashes, risks of osteoporosis, and other menopause symptoms. Certain factors positively affecting the growth of hormone replacement therapy (HRT) are increasing awareness of postmenopausal issues among women, hormonal imbalance disorders with the rising geriatric population, and a rise in drug development with novel delivery systems.

According to the UN, the global population will grow by 8.5 billion in 2030 and 9.7 billion in 2050. Common problems include weight gain, fatigue, memory decline, low libido, aging appearance, and muscle loss. However, the dangers of HRT vary with the Type, dose, and route of administration, use duration, and initiation age. As per this research study, The global hormone replacement therapy market size was US$ 18.04 Billion in 2022.

Type of Hormone Replacement Therapy

Based on Type, hormone replacement therapy is categorized into Estrogen, Human Growth, Thyroid, Testosterone, and Progestogen. Estrogen & progesterone replacement therapy dominated the HRT market. It continues to maintain its dominance in the future due to high demand due to the increasing number of women reaching Menopause. In addition, Estrogen plus progesterone therapy has a small increased risk of breast cancer, which is more significant with synthetic progestins. Hormone Replacement Therapy Industry is likely to grow with a CAGR of 6.82% during 2022-2027.

Disease Type of Hormone Replacement Therapy

Based on Disease type, Menopause will emerge as a significant disease segment for the colonoscopy devices industry. The rising number of women aged 45 to 60 years and the increasing incidence of vasomotor symptoms that may lead to severe conditions, such as osteoporosis, are projected to fuel market growth. As per the American Congress of Obstetricians and Gynecologists, around 6,000 ladies arrive at Menopause every day. In Sept 2021, Theramex announced the approval of Bijuva / Bijuve across Europe, body-identical HRT for estrogen deficiency symptoms in postmenopausal women with an intact uterus at least one year since last menses, which combines progesterone and estradiol in a single daily oral capsule.

The Route of Administration of Hormone Replacement Therapy

Based on the route of administration, the oral category dominated the market in 2022 owing to the rise in prescription rate. Around 120 million prescriptions of Levothyroxine sodium tablets are dispensed annually in the U.S. Parenteral is expected to witness the fastest growth. In addition, developing and approving long-acting products are expected to boost segment growth. For instance, in October 2021, Pfizer, Inc. received approval for its NGENLA (somatrogon), a once-a-week long-acting recombinant human growth hormone, from Health Canada to treat a patient with growth hormone deficiency.

Region Insights – Hormone Replacement Therapy Market

North America ruled the general market for hormone replacement therapy, owing to the growth hormone deficiency disorders and rise in the prevalence of Menopause and also high awareness of the therapy amongst the age group of 35 years and above patients. In addition, the Availability of advanced product launches of various treatments boosted the North American market.

Europe is the another most dominant region, owing to the geriatric population suffering from hypothyroidism, a surge in hormonal disorders in women suffering from menopausal symptoms, and a rise in growth hormone disorders. For instance, according to Frontier, in June 2021, the prevalence of thyroid disorders ranged from 0.2-5.3% in Europe. Thus, this is leading to an increase in demand for thyroid replacement therapies in Europe, further boosting the market growth in the region.

Asia Pacific is supposed to observe the quickest development over the forecast period. Expanding mindfulness levels and rising focal points of medical services suppliers on the destruction of hormonal lacks are supposed to help the market's growth inside the locale.

The market in Latin America and Middle East & Africa is expected to grow slower owing to the unmet needs of these therapies, low awareness among the population, reduced healthcare expenditure, and others. For instance, according to the National Library of Medicine, in December 2021, the prevalence of menopausal hormone therapy was 12.5% in these regions, which is still lower compared to the other areas globally. Furthermore, the launch of new products in this region by various key players may fuel the subsequent growth of the market.

Key Companies & Market Share Insights

Major global hormone replacement therapy players include Merck KgaA, Bayer AG, Pfizer Inc., Abbott Laboratories, Novartis AG, Novo Nordisk A/S, Amgen, Inc., F. Hoffmann-La Roche, and Eli Lilly and Company. In 2021, I-MAB Biopharma Co., Ltd. entered into a collaboration with Jumpcan Pharmaceutical Group for the development & commercialization of eftansomatropin alfa (TJ101) in China.

Renub Research latest report “Global Hormone Replacement Therapy Market, by Type (Estrogen, Human Growth, Thyroid, Progestogen and Testosterone), by Route of Administration (Oral, Parenteral, Transdemal and Others), by Disease type (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) and Company (Merck KgaA, Bayer AG, Pfizer Inc., Abbott Laboratories, Novartis AG, Novo Nordisk A/S, Amgen, Inc., F. Hoffmann-La Roche, and Eli Lilly and Company)” provides comprehensive details about Global Hormone Replacement Therapy Industry.

Type Outlook: Market has been covered from 5 viewpoints

1. Estrogen
2. Progesterone
3. Human Growth
4. Thyroid
5. Testosterone

Route of Administration Outlook: Market has been covered from 4 viewpoints

1. Oral
2. Parenteral
3. Transdermal
4. Others

Disease Type Outlook: Market has been covered from 5 viewpoints

1. Menopause
2. Hypothyroidism
3. Male Hypogonadism
4. Growth Hormone Deficiency
5. Others

Regional Outlook: Market has been covered from 5 viewpoints

1. North America
2. Europe
3. Asia Pacific
4. South America
5. Middle East & Africa

All companies have been covered into 3 viewpoints

• Overviews
• Recent Developments
• Revenues

Key Players Analysis

1. Merck KgaA
2. Bayer AG
3. Pfizer Inc.
4. Abbott Laboratories
5. Novartis AG
6. Novo Nordisk A/S
7. Amgen, Inc.
8. F. Hoffmann-La Roche
9. Eli Lilly and Company


1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Hormone Replacement Therapy Market
6. Market Share – Hormone Replacement Therapy Market
6.1 By Type
6.2 By Disease Type
6.3 Route of Administration
6.4 By Region
7. Type – Hormone Replacement Therapy Market
7.1 Estrogen
7.2 Human Growth
7.3 Thyroid
7.4 Testosterone
7.5 Progestogen
8. Disease Type - Hormone Replacement Therapy Market
8.1 Menopause
8.2 Hypothyroidism
8.3 Male Hypogonadism
8.4 Growth Hormone Deficiency
8.5 Others
9. Route of Administration - Hormone Replacement Therapy Market
9.1 Oral
9.2 Parenteral
9.3 Transdemal
9.4 Others
10. Region – Hormone Replacement Therapy Market
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Rest of World
11. Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Recent Initiatives
11.1.3 Net Sales
11.2 Novartis
11.2.1 Overview
11.2.2 Recent Initiatives
11.2.3 Net Sales
11.3 Pfizer
11.3.1 Overview
11.3.2 Recent Initiatives
11.3.3 Net Sales
11.4 Amgen
11.4.1 Overview
11.4.2 Recent Initiatives
11.4.3 Net Sales
11.5 Merck & Co
11.5.1 Overview
11.5.2 Recent Initiatives
11.5.3 Net Sales
11.6 Bayer
11.6.1 Overview
11.6.2 Recent Initiatives
11.6.3 Net Sales
11.7 Eli Lily
11.7.1 Overview
11.7.2 Recent Initiatives
11.7.3 Net Sales
11.8 Novo Nordisk
11.8.1 Overview
11.8.2 Recent Initiatives
11.8.3 Net Sales
11.9 F. Hoffmann-La Roche
11.9.1 Overview
11.9.2 Recent Initiatives
11.9.3 Net Sales
List of Figures:
Figure-01: Global – Hormone Replacement Therapy Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Hormone Replacement Therapy Market (Billion US$), 2023 – 2027
Figure-03: Type – Estrogen Market (Million US$), 2018 – 2022
Figure-04: Type – Forecast for Estrogen Market (Million US$), 2023 – 2027
Figure-05: Type – Human Growth Market (Million US$), 2018 – 2022
Figure-06: Type – Forecast for Human Growth Market (Million US$), 2023 – 2027
Figure-07: Type – Thyroid Market (Million US$), 2018 – 2022
Figure-08: Type – Forecast for Thyroid Market (Million US$), 2023 – 2027
Figure-09: Type – Testosterone Market (Million US$), 2018 – 2022
Figure-10: Type – Forecast for Testosterone Market (Million US$), 2023 – 2027
Figure-11: Type – Progestogen Market (Million US$), 2018 – 2022
Figure-12: Type – Forecast for Progestogen Market (Million US$), 2023 – 2027
Figure-13: Disease Type – Menopause Market (Million US$), 2018 – 2022
Figure-14: Disease Type – Forecast for Menopause Market (Million US$), 2023 – 2027
Figure-15: Disease Type – Hypothyroidism Market (Million US$), 2018 – 2022
Figure-16: Disease Type – Forecast for Hypothyroidism Market (Million US$), 2023 – 2027
Figure-17: Disease Type – Male Hypogonadism Market (Million US$), 2018 – 2022
Figure-18: Disease Type – Forecast for Male Hypogonadism Market (Million US$), 2023 – 2027
Figure-19: Disease Type – Growth Hormone Deficiency Market (Million US$), 2018 – 2022
Figure-20: Disease Type – Forecast for Growth Hormone Deficiency Market (Million US$), 2023 – 2027
Figure-21: Disease Type – Others Market (Million US$), 2018 – 2022
Figure-22: Disease Type – Forecast for Others Market (Million US$), 2023 – 2027
Figure-23: Route of Administration – Oral Market (Million US$), 2018 – 2022
Figure-24: Route of Administration – Forecast for Oral Market (Million US$), 2023 – 2027
Figure-25: Route of Administration – Parenteral Market (Million US$), 2018 – 2022
Figure-26: Route of Administration – Forecast for Parenteral Market (Million US$), 2023 – 2027
Figure-27: Route of Administration – Transdemal Market (Million US$), 2018 – 2022
Figure-28: Route of Administration – Forecast for Transdemal Market (Million US$), 2023 – 2027
Figure-29: Route of Administration – Others Market (Million US$), 2018 – 2022
Figure-30: Route of Administration – Forecast for Others Market (Million US$), 2023 – 2027
Figure-31: North America – Hormone Replacement Therapy Market (Million US$), 2018 – 2022
Figure-32: North America – Forecast for Hormone Replacement Therapy Market (Million US$), 2023 – 2027
Figure-33: Europe – Hormone Replacement Therapy Market (Million US$), 2018 – 2022
Figure-34: Europe – Forecast for Hormone Replacement Therapy Market (Million US$), 2023 – 2027
Figure-35: Asia Pacific – Hormone Replacement Therapy Market (Million US$), 2018 – 2022
Figure-36: Asia Pacific – Forecast for Hormone Replacement Therapy Market (Million US$), 2023 – 2027
Figure-37: Rest of World – Hormone Replacement Therapy Market (Million US$), 2018 – 2022
Figure-38: Rest of World – Forecast for Hormone Replacement Therapy Market (Million US$), 2023 – 2027
Figure-39: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2022
Figure-40: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-41: Novartis – Global Revenue (Billion US$), 2018 – 2022
Figure-42: Novartis – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-43: Pfizer – Global Revenue (Billion US$), 2018 – 2022
Figure-44: Pfizer – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-45: Amgen – Global Revenue (Billion US$), 2018 – 2022
Figure-46: Amgen – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-47: Merck & Co – Global Revenue (Billion US$), 2018 – 2022
Figure-48: Merck & Co – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-49: Bayer – Global Revenue (Billion US$), 2018 – 2022
Figure-50: Bayer – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-51: Eli Lily – Global Revenue (Billion US$), 2018 – 2022
Figure-52: Eli Lily – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-53: Novo Nordisk – Global Revenue (Billion US$), 2018 – 2022
Figure-54: Novo Nordisk – Forecast for Global Revenue (Billion US$), 2023 – 2027
Figure-55: F. Hoffmann-La Roche – Global Revenue (Billion US$), 2018 – 2022
Figure-56: F. Hoffmann-La Roche – Forecast for Global Revenue (Billion US$), 2023 – 2027
List of Tables:
Table-01: Global – Hormone Replacement Therapy Market Share by Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Hormone Replacement Therapy Market Share by Type (Percent), 2023 – 2027
Table-03: Global – Hormone Replacement Therapy Market Share by Disease Type (Percent), 2018 – 2022
Table-04: Global – Forecast for Hormone Replacement Therapy Market Share by Disease Type (Percent), 2023 – 2027
Table-05: Global – Hormone Replacement Therapy Market Share by Route of Administration (Percent), 2018 – 2022
Table-06: Global – Forecast for Hormone Replacement Therapy Market Share by Route of Administration (Percent), 2023 – 2027
Table-07: Global – Hormone Replacement Therapy Market Share by Regions (Percent), 2018 – 2022
Table-08: Global – Forecast for Hormone Replacement Therapy Market Share by Regions (Percent), 2023 – 2027

$3,990

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings